XML 55 R18.htm IDEA: XBRL DOCUMENT v3.26.1

Balance Sheet Details

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Details

6.Balance Sheet Details

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

		December 31,
		2025				2024
Research and development costs		$	4,700			$	1,222
Compensation-related expenses			2,913				225
Deferred offering costs			—				671
Other			422				173
Total accrued liabilities		$	8,035			$	2,291

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/210/tableOfContent

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration